Vanguard Group Inc. lifted its holdings in Vertex Pharmaceuticals by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 23,258,288 shares of the pharmaceutical company’s stock worth $ ...

The project has been developed and is owned by Green Tie Capital, and EPC is contracted by Elmya, featuring advanced solar technology including 33,600 Vertex modules and 580 Vanguard 1P trackers.